Skip to content
Wednesday, November 11, 2026
Novarel Express delivers cutting-edge technology updates, d…

The Zimbabwean Government Rejects ‘One-Sided’ US Health Aid Package Over Data Apprehensions

Medical aid image
The proposed US financial assistance would have supported programmes for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has turned down a substantial American health deal valued at $367m (272 million pounds) over five years because of Washington's request for confidential information.

This rejection was revealed following a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa felt the deal was "skewed".

A government spokesman later stated that the US was demanding access to health data for scientific study and profit but was not willing to share the benefits from future treatments.

"We will now turn to the challenging and unfortunate task of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the United States had donated more than $1.9bn in health funding to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has urged further negotiations to find a agreement agreeable to both sides so the nation's vital HIV programme can proceed.

Wider Implications

Zimbabwe's decision follows a similar case in neighbouring Kenya, where a high court blocked a related deal with the US following legal challenges were filed about the security of Kenyans' medical information.

After resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).

The agency had administered aid for the US government, but Trump stated its spending was "inefficient" and his administration was pursuing direct bilateral deals to boost openness and responsibility.

As per statements, Sixteen African countries have to date agreed to similar health pacts, representing more than $18.3bn in new funding.

Details of the Rejected Deal

The money for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this collaboration could have provided immense benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via American-funded programmes," Tremont added.

However, official spokesman Nick Mangwana said the arrangement was "unequal".

"Our nation was requested to surrender its biological resources and data for a long time, without any corresponding assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.

"In essence, our nation would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be available to our citizens should a future pandemic arise."

National Interest and International Frameworks

He also said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending frameworks already set up through the global organization.

Mangwana cited its Pandemic Benefit-Sharing framework designed to manage potential pandemics.

"This system is designed to guarantee that when a country provides its data, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to develop them."

These objections over the US deal "must not be interpreted as opposition to America," he added.

"We encourage continued discussions with our US partners on how subsequent collaboration could be structured in a manner that respects the sovereignty and interests of each country."

Medical Community Reaction

A leading public health body said it understood the government's concerns, but urged that negotiations need to persist given that much of the nation's HIV programmes relied on external financing.

"Where specific concerns arise, including those involving information security or implementation frameworks, these can often be addressed via technical clarification and negotiated safeguards," the group said.

The situation underscores the continuing tensions between accepting vital international aid and protecting national sovereignty in an ever more data-driven world.

About the author

Mary Mccarthy

A tech journalist with over a decade of experience covering AI, cybersecurity, and emerging digital innovations.

Novarel Express

Type to search articles.